Circulating PCSK9 and Risk of Myocardial Infarction

Circulating PCSK9 and Risk of Myocardial Infarction

The usefulness of circulating proprotein convertase subtilisin-kexin type 9 (PCSK9) as a risk marker of coronary heart disease in the general population remains unclear. In a nested case-control study in Norway, 1,488 incident myocardial infarctions were registered during 11.3 years of follow-up and...

Full description

Bibliographic Details
Main Authors: Lars E. Laugsand, MD, PhD, Bjørn O. Åsvold, MD, PhD, Lars J. Vatten, MD, PhD, Imre Janszky, MD, PhD, Carl G. Platou, MD, Annika E. Michelsen, PhD, Jan K. Damås, MD, PhD, Pål Aukrust, MD, PhD, Thor Ueland, PhD
Format: Article
Language:English
Published: Elsevier 2016-12-01
Series:JACC: Basic to Translational Science
Subjects:
PCSK9 inflammation
epidemiology
myocardial infarction
prospective study
risk factors
Online Access:http://www.sciencedirect.com/science/article/pii/S2452302X16300997

Internet

http://www.sciencedirect.com/science/article/pii/S2452302X16300997

Similar Items